Tao Gong1, Yuanyuan Xiang2, Muhammad G Saleh3,4, Fei Gao1, Weibo Chen5, Richard A E Edden3,4, Guangbin Wang1. 1. Department of MR, Shandong Medical Imaging Research Institute, Shandong University, Jinan, Shandong, P.R. China. 2. Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, P.R. China. 3. Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 4. F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA. 5. Philips Healthcare, Shanghai, P.R. China.
Abstract
BACKGROUND: Parkinson's disease (PD) is divided into postural instability gait difficulty (PIGD) and tremor-dominant (TD) subtypes. Increasing evidence has suggested that the GABAergic neurotransmitter system is involved in the pathogenesis of PD. PURPOSE: To evaluate the differences of GABA levels between PD motor subtypes using MEscher-GArwood Point Resolved Spectroscopy (MEGA-PRESS). STUDY TYPE: COHORT.: SUBJECTS: PD patients were classified into PIGD (n = 13) and TD groups (n = 9); 16 age- and sex-matched healthy controls were also recruited. All subjects were right-handed. SEQUENCE: All subjects underwent an magnetic resonance spectroscopy scan including MEGA-PRESS at 3.0T. ASSESSMENT: The detected GABA signal also contains signal from macromolecules (MM) and homocarnosine, so it is referred to as GABA+. GABA + levels and Creatine (Cr) levels were quantified in the left basal ganglia (BG) using Gannet 2.0 by Tao Gong. STATISTICAL TESTS: Differences in GABA + levels between the three groups were analyzed using analysis of covariance. The relationship between GABA levels and a unified PD rating scale (UPDRS) was also analyzed. RESULTS: GABA + levels were significantly lower in left BG regions of PD patients compared with healthy controls (P < 0.001). In PD patients, the GABA concentration was lower in the TD group than the PIGD group (P = 0.019). Cr levels in PIGD and TD were lower than controls (P = 0.020; P = 0.002). A significant negative correlation was found in PIGD between GABA levels and UPDRS (r = -0.572, P = 0.041), while no correlation was found in TD (r = -0.339, P = 0.372). DATA CONCLUSION: Low BG GABA levels in PD patients, and differences between PIGD/TD patients, suggest that GABAergic dysfunction may play an important role in the pathogenesis of Parkinson's disease. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;47:1610-1615.
BACKGROUND:Parkinson's disease (PD) is divided into postural instability gait difficulty (PIGD) and tremor-dominant (TD) subtypes. Increasing evidence has suggested that the GABAergic neurotransmitter system is involved in the pathogenesis of PD. PURPOSE: To evaluate the differences of GABA levels between PD motor subtypes using MEscher-GArwood Point Resolved Spectroscopy (MEGA-PRESS). STUDY TYPE: COHORT.: SUBJECTS:PDpatients were classified into PIGD (n = 13) and TD groups (n = 9); 16 age- and sex-matched healthy controls were also recruited. All subjects were right-handed. SEQUENCE: All subjects underwent an magnetic resonance spectroscopy scan including MEGA-PRESS at 3.0T. ASSESSMENT: The detected GABA signal also contains signal from macromolecules (MM) and homocarnosine, so it is referred to as GABA+. GABA + levels and Creatine (Cr) levels were quantified in the left basal ganglia (BG) using Gannet 2.0 by Tao Gong. STATISTICAL TESTS: Differences in GABA + levels between the three groups were analyzed using analysis of covariance. The relationship between GABA levels and a unified PD rating scale (UPDRS) was also analyzed. RESULTS:GABA + levels were significantly lower in left BG regions of PDpatients compared with healthy controls (P < 0.001). In PDpatients, the GABA concentration was lower in the TD group than the PIGD group (P = 0.019). Cr levels in PIGD and TD were lower than controls (P = 0.020; P = 0.002). A significant negative correlation was found in PIGD between GABA levels and UPDRS (r = -0.572, P = 0.041), while no correlation was found in TD (r = -0.339, P = 0.372). DATA CONCLUSION: Low BG GABA levels in PDpatients, and differences between PIGD/TD patients, suggest that GABAergic dysfunction may play an important role in the pathogenesis of Parkinson's disease. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;47:1610-1615.
Authors: P E Menschikov; N A Semenova; M V Ublinskiy; T A Akhadov; R A Keshishyan; I S Lebedeva; M A Omelchenko; V G Kaleda; S D Varfolomeev Journal: Dokl Biochem Biophys Date: 2016-07-15 Impact factor: 0.788
Authors: Richard A E Edden; Georg Oeltzschner; Ashley D Harris; Nicolaas A J Puts; Kimberly L Chan; Vincent O Boer; Michael Schär; Peter B Barker Journal: J Magn Reson Imaging Date: 2016-05-30 Impact factor: 4.813
Authors: M Gerlach; W Gsell; J Kornhuber; K Jellinger; V Krieger; F Pantucek; R Vock; P Riederer Journal: Brain Res Date: 1996-11-25 Impact factor: 3.252
Authors: Yan Li; Radhika Srinivasan; Helene Ratiney; Ying Lu; Susan M Chang; Sarah J Nelson Journal: J Magn Reson Imaging Date: 2008-08 Impact factor: 4.813
Authors: Robert J Buchanan; David P Darrow; Kevin T Meier; Jennifer Robinson; Dawn M Schiehser; David C Glahn; Zoltan Nadasdy Journal: Front Hum Neurosci Date: 2014-03-07 Impact factor: 3.169
Authors: Yulu Song; Peter J Lally; Maria Yanez Lopez; Georg Oeltzschner; Mary Beth Nebel; Borjan Gagoski; Steven Kecskemeti; Steve C N Hui; Helge J Zöllner; Deepika Shukla; Tomoki Arichi; Enrico De Vita; Vivek Yedavalli; Sudhin Thayyil; Daniele Fallin; Douglas C Dean; P Ellen Grant; Jessica L Wisnowski; Richard A E Edden Journal: Neuroradiology Date: 2021-10-15 Impact factor: 2.995
Authors: Muhammad G Saleh; Daniel Rimbault; Mark Mikkelsen; Georg Oeltzschner; Anna M Wang; Dengrong Jiang; Ali Alhamud; Jamie Near; Michael Schär; Ralph Noeske; James B Murdoch; Lars Ersland; Alexander R Craven; Gerard Eric Dwyer; Eli Renate Grüner; Li Pan; Sinyeob Ahn; Richard A E Edden Journal: Neuroimage Date: 2019-01-22 Impact factor: 6.556
Authors: Tao Gong; Xia Zhang; Xinhong Wei; Shuhui Yuan; Muhammad G Saleh; Yulu Song; Richard A Edden; Guangbin Wang Journal: Neurochem Int Date: 2020-10-22 Impact factor: 3.921
Authors: Kaleen M Lavin; Stuart C Sealfon; Merry-Lynn N McDonald; Brandon M Roberts; Katarzyna Wilk; Venugopalan D Nair; Yongchao Ge; Preeti Lakshman Kumar; Samuel T Windham; Marcas M Bamman Journal: J Appl Physiol (1985) Date: 2019-12-12
Authors: Annelies J M van Nuland; Hanneke E M den Ouden; Heidemarie Zach; Michiel F M Dirkx; Jack J A van Asten; Tom W J Scheenen; Ivan Toni; Roshan Cools; Rick C Helmich Journal: Hum Brain Mapp Date: 2019-11-13 Impact factor: 5.038
Authors: Beate Pesch; Swaantje Casjens; Dirk Woitalla; Shalmali Dharmadhikari; David A Edmondson; Maria Angela Samis Zella; Martin Lehnert; Anne Lotz; Lennard Herrmann; Siegfried Muhlack; Peter Kraus; Chien-Lin Yeh; Benjamin Glaubitz; Tobias Schmidt-Wilcke; Ralf Gold; Christoph van Thriel; Thomas Brüning; Lars Tönges; Ulrike Dydak Journal: Cells Date: 2019-01-29 Impact factor: 6.600